Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).

被引：0

作者：

Yorozu, Atsunori

Namiki, Mikio

Saito, Shiro

Egawa, Shin

Yaegashi, Hiroshi

Hiroyuki, Konaka

Momma, Tetsuo

Fukagai, Takashi

Tanaka, Nobumichi

Ohashi, Toshio

Takahashi, Hiroyuki

Mizokami, Atsushi

Nakagawa, Yoko

Kikuchi, Takashi

Stone, Nelson

机构：

[1] Natl Hosp Org Tokyo Med Ctr, Tokyo, Japan

[2] Hasegawa Hosp, Toyama, Japan

[3] Ofuna Chuo Hosp, Kamakura, Kanagawa, Japan

[4] Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan

[5] Kanazawa Univ, Kanazawa, Ishikawa, Japan

[6] Japanese Red Cross Soc, Kanazawa Hosp, Kanazawa, Ishikawa, Japan

[7] Showa Univ, Sch Med, Tokyo, Japan

[8] Nara Med Univ, Sch Med, Nara, Japan

[9] Keio Univ, Sch Med, Tokyo, Japan

[10] Jikei Univ, Sch Med, Tokyo, Japan

[11] Translat Res Ctr Med Innovat, Kobe, Hyogo, Japan

[12] Mt Sinai Med Ctr, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

305

引用

页数：1